1
/
3
/

Our Services

Defocus Media is the pulse of the optometric industry. Our expertise at Defocus Media is creating completely custom social media services for eyecare professionals. Our company manages social media networks for optometrists, including Facebook, Twitter and Instagram. In addition to providing social media management for optometrist, we assist in providing eyecare professionals with the latest in optometric industry news, eyewear trends and discussions of the hottest topics in the eyecare profession.

Social Media Management for Optometrists

We offer three packages to bring your social media accounts to perfect 20/20 clarity. Our packages allow you to choose topics for post customization based on the services your office provides.

MicroFocus Package

Motivated to manage your own social media? We’ve got you covered with a day-by-day road map to drive engagement on your social media feed.

See features

Fixed Focus Package

This package is ideal for a practice that has an established social media presence, but wants to pass over the day to day management to our team.

See features

HyperFocus Package

Looking for a full-fledged social media assault? This package will build an entirely customized and unique social media presence.

See features

Podcast Episodes

Stay up to date with the latest in optometry industry news, eyewear trends and the hottest topics in our profession on the Defocus Podcast.

Optometry Podcast: Dr. Thomas Hunter Discusses Glaucoma Awareness

January 15, 2018
With over 3 million Americans diagnosed with glaucoma, and an estimated 6 million by 2050, it’s shocking to think we haven’t had a new innovation in pharmaceutical treatment of the disease in nearly 20 years. All that changed quite rapidly as 2017 came to a close last month with the introduction of not one, but two novel glaucoma therapies. Vyzulta combines our beloved first line prostaglandin analogue with nitric oxide, a potent vasodilator. The novel approach targets IOP reduction by increasing outflow through the trabecular meshwork and Schlemm’s canal. The combination is a once daily drop that showed statistically significant IOP reduction compared to prostaglandin latanoprost alone, as well as tried and true Timolol. Many feel this drop could overtake latanoprost as first-line glaucoma treatment (pending affordability and insurance coverage of course). Rhopressa gained FDA approval in December as the first ever Rho kinase inhibitor medication for glaucoma. The novel once daily drop increases outflow through the trabecular meshwork, and is the first drop shown to reduce episcleral venous pressure.  While head to head study data did not show superiority against Timolol in patients with IOP > 25 mmHg, it was more effective than Timolol at pressures under 25 mmHg. As such the drop is being marketed as a second line treatment, with advantages including its’ once daily dosage and potentially superior effectiveness in cases of low pressure glaucoma where reducing episcleral venous pressure is essential. Glaucoma and cataract specialist Dr. Thomas Hunter of Duke Eye Center discusses these new medications and how they will fit into his specialty practice, as well as surgical updates in treating glaucoma and collaborating between ODs and MDs on glaucoma care in this week’s podcast in honor of Glaucoma Awareness Month!

Optometry Podcast: DEWS II Review

December 17, 2017
In a year of online disruptors, powerhouse mergers, and legislative battles, the story that most affects the day to day practice of optometrists in 2017 had several major contenders.  But with an estimated 30+million Americans suffering from dry eye, a condition that we’ve been struggling to treat for decades, the DEWS II report stands out as a groundbreaking new mindset in what bread and butter patient care should look like.  Aren’t so sure? If you’ve just skimmed a few summary articles and are thinking “it’s not really changed much for me” we’re highlighting the biggest takeaways that will make you rethink what you think you know about dry eye treatment in our podcast with Dr. Jennifer Craig, Dr. Lyndon Jones, and Dr. James Wolffsohn 1. Stop focusing on Aqueous Deficient versus Evaporative Dry Eye Disease. If you’ve been putting energy in thinking that differentiating between these two different types of dry eye is essential to management, it’s time to rethink everything.  The DEWS II report presents a much more modern understanding of dry eye, where aqueous deficiency and meibomian gland dysfunction are seen together in almost all patients.  In fact, most studies show around 80% of people with dry eye have “mixed mechanism” where meibomian gland dysfunction is also a component.  Instead of separating dry eye into two artificial categories, the DEWS II report defines dry eye syndrome as a loss of homeostasis within the entire lacrimal system:  from lids to glands, to goblet cells.  Treating patients means bringing all tear components into proper balance. 2. Pain and discomfort aren’t always treatable, and shouldn’t be the goal when treating dry eye. We’ve all had patients that have symptoms significantly worse than their ocular surface signs, so this finding of the DEWS II report is not a surprise.  But in the day to day patient care it’s great to have a clear knowledge of what we are treating and how we can do that as optometrists.  Our focus is getting the ocular surface elements in balance and achieving that critical homeostasis.  If we can get our patients to normal tear film osmolarity and resolve inflammation, heal all corneal and conjunctival staining, and restore meibomian gland function, then we have treated dry eye.  If pain still persists, then a referral for pain management is needed because we have done all we can do with the ocular surface.  We now have a defined goal for what treating dry eye can achieve, and if neuropathic pain persists, we’ll need to comanage with neuropathic pain management specialists.  The DEWS II report shows us what success looks like, and gives us a clear path on what our treatments aim to accomplish, and what aspects of the patient’s presentation we can’t treat alone. 3. Dry Eye doesn’t look like a middle-aged woman. A section of the report is how age and gender affects the prevalence of dry eye, but the key take home is to look for dry eye everywhere.  While there are demographics where the condition

Optometry Podcast: 2017 Wrap Up with Dr. Jaclyn Garlich of 20/20 Glance

December 10, 2017
Think you’re up to date on what’s happening in optometry? A friend of the podcast Dr. Jackie Garlich of 20/20 Glance drops in to test our skills on optometry news, research, and pop culture.  You can study up by making sure you subscribe to her excellent weekly email newsletter and following her on Instagram @2020glance !

Optometry Podcast: Let’s Talk Referrals with Dr. Jessica Tegen

December 4, 2017
Building your practice? Getting referrals from your community is a great place to start. How do you stand out in your community as a go-to provider, and approach doctors and community leaders outside of eyecare about the benefit of our profession? Dr. Jessica Tegen of Madras Vision Source weighs in on how she built her pediatric specialty practice. 1. Meet face to face. Instead of just sending a blanket note of introduction, Dr. Tegen recommends scheduling time to establish a personal relationship with MDs in your community. Cater lunch for staff and/or bring a gift basket or something that reflects the doctor’s personal tastes or interests. Focus on creating a mutual collaboration and ask how you can refer patients to them! 2. Get involved at schools. If you are specializing in pediatric care or vision therapy, or just want to grow pediatric and young parent-patient demographics, referrals from teachers are a must. Whether you offer school vision screenings, sponsor a fundraiser or cater food for a PTA meeting, or sponsor a local youth sports teams, there are plenty of ways to get involved. 3. Don’t forget about fellow optometry referrals. Dr. Tegen stays active in her state and local optometric society to meet fellow ODs and collaborate on referrals to get her patients the care they need. The key to successful optometric referrals is to approach it the right way.  Within optometry, we are colleagues – not competitors. We discuss local civic groups and public health organizations to drive referrals, keys to referral letter writing, and what patient care offerings bring in the most referrals in this week’s podcast!

Our Team of Experts

Defocus Media is run by two successful Millennial optometrists and social media entrepreneurs, Dr. Jennifer Lyerly and Dr. Darryl Glover.  They have proven track records of successfully engaging online readers and followers, and are bringing their expertise to your media accounts.

Meet the Social Media Gurus

Dr. Jennifer Lyerly

Dr. Darryl Glover